The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
Condition: Charcot Marie Tooth Disease, Type 1 Intervention: Drug: CLZ-2002 Sponsor: Cellatoz Therapeutics, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Charcot-Marie-Tooth Disease | Research